Clincosm LogoSign in Get a demo

Obesity

Showing NaN - NaN of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity Trial in United States (Cagrilintide, Semaglutide, Tirzepatide)

Not yet recruiting
  • Obesity
  • Birmingham, Alabama
  • +44 more
Nov 9, 2023

Obesity, Overweight, Knee Pain Chronic Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • +4 more
  • Phoenix, Arizona
  • +168 more
Jul 10, 2023

Obesity Trial in United States (Semaglutide 2.4 mg and NNC0165-1875 2.0 mg, Semaglutide 2.4 mg and 2.0 mg, Semaglutide 2.4 mg

Completed
  • Obesity
  • Semaglutide 2.4 mg and NNC0165-1875 2.0 mg
  • +3 more
  • Walnut Creek, California
  • +13 more
Jan 23, 2023

Obesity Trial in Worldwide (semaglutide 2.4 mg, semaglutide 2.4 mg ())

Active, not recruiting
  • Obesity
  • semaglutide 2.4 mg
  • semaglutide 2.4 mg (placebo)
  • Montgomery, Alabama
  • +64 more
Jan 24, 2023

Overweight, Obesity Trial (Semaglutide, Placebo semaglutide)

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +21 more
Jan 24, 2023

Obesity Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Recruiting
  • Obesity
  • Birmingham, Alabama
  • +225 more
Jan 24, 2023

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +804 more
Dec 19, 2022

Obesity Trial in Worldwide (Placebo, PF-06882961)

Active, not recruiting
  • Obesity
  • Anniston, Alabama
  • +40 more
Jun 29, 2022

Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)

Completed
Has Results
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +18 more
Apr 26, 2022

Obesity, Overweight Trial in Worldwide (Oral semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Obesity
  • Overweight
  • Oral semaglutide
  • Placebo (semaglutide)
  • Birmingham, Alabama
  • +50 more
Jan 26, 2022

Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide))

Completed
Has Results
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +40 more
Nov 10, 2021

Obesity, Overweight Trial in Worldwide (Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide))

Completed
Has Results
  • Obesity
  • Overweight
  • Semaglutide 1.0 mg
  • +3 more
  • Buena Park, California
  • +146 more
Nov 8, 2021

Gut Microbiota Composition in Hispanic and Non-Hispanic

Completed
  • Obesity
  • Fecal Sample Collection
  • +3 more
  • Wilmington, Delaware
    Nemours/AI duPont Hospital for Children
Jun 26, 2020

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (Liraglutide 3.0 mg, Placebo)

Completed
Has Results
  • Metabolism and Nutrition Disorder
  • Obesity
  • Liraglutide 3.0 mg
  • Placebo
  • Birmingham, Alabama
  • +53 more
Mar 13, 2020

Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

Completed
Has Results
  • Cardiovascular Disease
  • +4 more
  • Lorcaserin hydrochloride
  • Placebo
  • Alexander City, Alabama
  • +498 more
Jun 27, 2019

Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States

Unknown status
Has Results
  • Endometrial Clear Cell Adenocarcinoma
  • +6 more
  • 3-Dimensional Conformal Radiation Therapy
  • +7 more
  • Birmingham, Alabama
  • +539 more
Mar 8, 2019

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Metabolism and Nutrition Disorder
  • Obesity
  • Vestavia Hills, Alabama
  • +160 more
Dec 6, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Canada, United States (liraglutide, )

Completed
Has Results
  • Metabolism and Nutrition Disorder
  • Obesity
  • Goodyear, Arizona
  • +36 more
Sep 29, 2017

Metabolism and Nutrition Disorder, Obesity, Obstructive Sleep Apnoea Trial in Canada, United States (liraglutide, )

Completed
Has Results
  • Metabolism and Nutrition Disorder
  • +2 more
  • Glendale, California
  • +41 more
Sep 29, 2017

Obesity, Overweight Trial in United States (NB32, PBO, Weight Management Program)

Terminated
Has Results
  • Obesity
  • Overweight
  • Birmingham, Alabama
  • +223 more
Feb 24, 2017

Obesity, Cardiovascular Diseases Trial in United States (Naltrexone HCl/Bupropion HCl ER, Placebo)

Terminated
Has Results
  • Obesity
  • Cardiovascular Diseases
  • Naltrexone HCl/Bupropion HCl ER
  • Placebo
  • Alexander City, Alabama
  • +138 more
Feb 21, 2017

Obesity, Overweight Trial in United States (NB, CLI, Usual Care)

Completed
Has Results
  • Obesity
  • Overweight
  • Denver, Colorado
  • +14 more
Nov 30, 2015

Overweight, Obesity Trial in Wilmington (NAP-SACC Child Care Wellness Program)

Completed
  • Overweight
  • Obesity
  • NAP-SACC Child Care Wellness Program
  • Wilmington, North Carolina
    Child Care Centers
Aug 9, 2013

Obesity Trial in Worldwide (CP-945,598 Treatment B, CP-945,598 Treatment A, Placebo)

Terminated
  • Obesity
  • CP-945,598 Treatment B
  • +2 more
  • Peoria, Arizona
  • +60 more
Nov 5, 2012

Obesity Trial in United States (LY377604, Sibutramine, Metoprolol)

Terminated
Has Results
  • Obesity
  • Mesa, Arizona
  • +20 more
Jun 2, 2011